Researchers in PNAS highlight the significant impact of microbe-host interactions on human emotions, cognition, and behavior, urging for built environment (BE) designs that consider microbiome diversity to enhance health and well-being.
FDA approves Iovance’s cell therapy for melanoma, the first treatment based on tumor-infiltrating lymphocytes
An experimental approach to treating cancer more than 40 years in the making finally has a long-sought and repeatedly delayed green light from the FDA.
February 17, 2024